Cardiol Therapeutics Inc.
CRDL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $126 | $153 | $115 | $129 |
| - Cash | $12 | $18 | $23 | $31 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $115 | $135 | $92 | $98 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$10 | -$8 | -$8 | -$6 |
| % Margin | – | – | – | – |
| Net Income | -$10 | -$8 | -$8 | -$6 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.12 | -0.1 | -0.1 | -0.12 |
| % Growth | -20% | 0% | 16.7% | – |
| Operating Cash Flow | -$7 | -$5 | -$7 | -$6 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$7 | -$5 | -$7 | -$6 |